Biochemical Relapse After Primary Treatment for Prostate Cancer: Studies on Natural History and Therapeutic Considerations

Author： Rosenbaum Eli   Partin Alan   Eisenberger Mario A.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.2, Iss.3, 2004-05, pp. : 249-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for biochemical recurrences after therapy for localised prostate cancer

By Ornstein David K   Gaston Kris E  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 657-669

Informa Healthcare

Access to resources Recommend Favorite

Options for prostate cancer after curative treatment failure

By  

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Therapeutic Application of Natural Medicine Monomers in Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 24, Iss. 34, 2017-11 ,pp. : 3681-3697

Bentham Science Publishers

Access to resources Recommend Favorite

Docetaxel plus estramustine and 15-month androgen deprivation therapy is feasible for the treatment of early prostate cancer relapse

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer

By Edwards Joanne  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 605-614

Informa Healthcare

Access to resources Recommend Favorite